Skip to main content
HSCS
NASDAQ Industrial Applications And Services

HeartSciences Amends Fortitude Mining Merger Terms, Adds Reverse-Split Protection

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$2.53
Mkt Cap
$9.866M
52W Low
$1.63
52W High
$4.3
52W Position info
55% above low
Off High info
41% below high
Rel. Volume
Market data snapshot near publication time

HSCS sits 55% above its 52-week low of $1.63.

Summary

HeartSciences amended its merger agreement with Fortitude Mining Holdings to clarify redemption mechanics, change shareholder consent rules, and add a reverse-stock-split adjustment to the merger consideration—a material protection given HeartSciences' distressed financial condition.


Key Events · M&A and Partnerships · HSCS

  • Merger Amendment Filed

    HeartSciences entered into Amendment No. 1 to the June 23, 2026 merger agreement with Fortitude Mining Holdings, modifying the A&R LLC Agreement, Parent New Charter, and adding a reverse-split adjustment clause.

  • Reverse-Split Protection Added

    New Section 2.06 adjusts the Merger Consideration, Exchange Ratio, and other terms if HeartSciences executes a reverse stock split between signing and closing, protecting Fortitude's owners from dilution.

  • Governance Changes

    The amendment replaces the form of Parent New Charter to propose changes to shareholder action by written consent, potentially altering post-merger governance.

  • Financial Distress Context

    HeartSciences' July 23 10-K disclosed a going-concern warning, material weaknesses, and stockholders' equity of just $0.2 million, making the reverse-split provision a critical deal-protection mechanism.


Analysis · HSCS · Industrial Applications And Services

An amendment to the all-stock merger with Fortitude Mining Holdings—originally announced on June 23, 2026—has been filed by HeartSciences. The revised terms clarify redemption mechanics in the LLC agreement, modify shareholder consent rules in the new charter, and, most critically, introduce a provision that adjusts the merger consideration and exchange ratio should HeartSciences execute a reverse stock split before closing. Given the going-concern warning, near-zero equity, and Nasdaq listing risk disclosed in the July 23 10-K, this reverse-split adjustment serves as a material protection for Fortitude's owners and signals that a reverse split is a live possibility. The amendment keeps the deal on track but highlights the financial fragility of the acquirer.

At the time of this filing, HSCS was trading at $2.53 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $9.9M. The 52-week trading range was $1.63 to $4.30. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HSCS - Latest Insights

HSCS
Jul 27, 2026, 4:28 PM EDT
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $2.53
Real-time Price: $2.35 info
Change: -$0.180 (-7%) info
Market Cap: $9.866M info
HSCS
Jul 23, 2026, 4:48 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $2.44
Real-time Price: $2.35 info
Change: -$0.090 (-4%) info
Market Cap: $9.866M info
HSCS
Jul 10, 2026, 5:02 PM EDT
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $2.74
Real-time Price: $2.35 info
Change: -$0.390 (-14%) info
Market Cap: $9.866M info
HSCS
Jun 26, 2026, 5:23 PM EDT
Filing Type: DEFA14A
Importance Score:
9
Price at Filing: $2.80
Real-time Price: $2.35 info
Change: -$0.4501 (-16%) info
Market Cap: $9.866M info
HSCS
Jun 26, 2026, 5:22 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.80
Real-time Price: $2.35 info
Change: -$0.4501 (-16%) info
Market Cap: $9.866M info